203 related articles for article (PubMed ID: 4596999)
1. Shigellosis in custodial institutions. 3. Prospective clinical and bacteriologic surveillance of children vaccinated with oral attenuated shigella vaccines.
Levine MM; Gangarosa EJ; Werner M; Morris GK
J Pediatr; 1974 Jun; 84(6):803-6. PubMed ID: 4596999
[No Abstract] [Full Text] [Related]
2. Shigellosis in custodial institutions. II. Clinical, immunologic and bacteriologic response of institutionalized children to oral attenuated shigella vaccines.
Levine MM; Dupont HL; Gangarosa EJ; Hornick RB; Snyder MJ; Libonati JP; Glaser K; Formal SB
Am J Epidemiol; 1972 Jul; 96(1):40-9. PubMed ID: 4557072
[No Abstract] [Full Text] [Related]
3. An outbreak of Sonne shigellosis in a population receiving oral attenuated shigella vaccines.
Levine MM; Rice PA; Gangarosa EJ; Morris GK; Snyder MJ; Formal SB; Wells JG; Gemski P; Hammond J
Am J Epidemiol; 1974 Jan; 99(1):30-6. PubMed ID: 4590191
[No Abstract] [Full Text] [Related]
4. Shigellosis in custodial institutions. V. Effect of intervention with streptomycin-dependent Shigella sonnei vaccine in an institution with endemic disease.
Levine MM; Gangarosa EJ; Barrow WB; Weiss CF
Am J Epidemiol; 1976 Jul; 104(1):88-92. PubMed ID: 779465
[TBL] [Abstract][Full Text] [Related]
5. Live oral Shigella vaccine: vaccination schedule and the effect of booster dose.
Mel DM; Arsic BL; Radovanovic ML; Litvinjenko SA
Acta Microbiol Acad Sci Hung; 1974; 21(1-2):109-14. PubMed ID: 4613128
[No Abstract] [Full Text] [Related]
6. Prospective cohort studies of shigellosis during military field training.
Cohen D; Sela T; Slepon R; Yavzori M; Ambar R; Orr N; Robin G; Shpielberg O; Eldad A; Green M
Eur J Clin Microbiol Infect Dis; 2001 Feb; 20(2):123-6. PubMed ID: 11305466
[TBL] [Abstract][Full Text] [Related]
7. Technological aspect of the production of live dysentery vaccines for oral administration.
Denchev V; Nenkov P; Vitanov T; Sumerska T; Marinova S; Vassilev T; Panova I; Bratoeva M; Linde K
Acta Microbiol Hung; 1991; 38(2):121-6. PubMed ID: 1805499
[TBL] [Abstract][Full Text] [Related]
8. Serum antibodies to lipopolysaccharide and natural immunity to shigellosis in an Israeli military population.
Cohen D; Green MS; Block C; Rouach T; Ofek I
J Infect Dis; 1988 May; 157(5):1068-71. PubMed ID: 3283258
[No Abstract] [Full Text] [Related]
9. [Prevention of bacillary dysentery using a live anti-dysentery vaccine in a group of neuropsychopathic children].
Meitert T; Istrati G; Sulea IT; Baron E; Andronescu C; Gogulescu L; Templea C; Ianopol L; Galan L; Fleşeriu M; Onciu C; Bogos L; Lupovici R; Boghiţoiu G; Ohmt E; Popescu G; Mihailiuc I; Maftei S; Tapu T; Zebreniuc D
Arch Roum Pathol Exp Microbiol; 1973 Mar; 32(1):35-44. PubMed ID: 4585403
[No Abstract] [Full Text] [Related]
10. Successful field trials with oral killed Shigella sonnei vaccine.
Grahneis H
Acta Microbiol Acad Sci Hung; 1974; 21(1-2):75-80. PubMed ID: 4613141
[No Abstract] [Full Text] [Related]
11. Immunity in shigellosis. II. Protection induced by oral live vaccine or primary infection.
DuPont HL; Hornick RB; Snyder MJ; Libonati JP; Formal SB; Gangarosa EJ
J Infect Dis; 1972 Jan; 125(1):12-6. PubMed ID: 4550416
[No Abstract] [Full Text] [Related]
12. [Pathogenic surveillance and related factors on bacillary dysentery in Beijing, 2008-2017].
Jia L; Lyu B; Tian Y; Zhang X; Liu ZC; Peng H; Li HJ; Zhen BJ; Wang XL; Huang Y; Qu M; Wang QY
Zhonghua Liu Xing Bing Xue Za Zhi; 2019 Feb; 40(2):165-169. PubMed ID: 30744266
[No Abstract] [Full Text] [Related]
13. Immunity in shigellosis. I. Response of man to attenuated strains of Shigella.
DuPont HL; Hornick RB; Snyder MJ; Libonati JP; Formal SB; Gangarosa EJ
J Infect Dis; 1972 Jan; 125(1):5-11. PubMed ID: 4550417
[No Abstract] [Full Text] [Related]
14. Prophylaxis of bacillary dysentery by liver vaccine Vadizen (Sh. flexneri T32-Istrati) in children collectivities in IS County.
Oană C; Buzdugan T; Constantiniu S; Cismaru M; Alexandru D; Dunea C; Funiac A; Radu M; Grumăzescu C; Meitert T
Arch Roum Pathol Exp Microbiol; 1984; 43(3-4):331-5. PubMed ID: 6400307
[No Abstract] [Full Text] [Related]
15. An 11-year study of shigellosis and Shigella species in Taiyuan, China: Active surveillance, epidemic characteristics, and molecular serotyping.
Zhao L; Xiong Y; Meng D; Guo J; Li Y; Liang L; Han R; Wang Y; Guo X; Wang R; Zhang L; Gao L; Wang J
J Infect Public Health; 2017; 10(6):794-798. PubMed ID: 28188118
[TBL] [Abstract][Full Text] [Related]
16. Reduction of morbidity due to bacillary dysentery by live vaccine Vadizen (Sh. flexneri T32-Istrati) in children collectivities in BH County.
Pop C; Cernea L; Ciortea A; Ianossy L; Kallay T; Lugoş A; Meitert T; Ciudin L; Pencu E
Arch Roum Pathol Exp Microbiol; 1984; 43(3-4):351-6. PubMed ID: 6400310
[No Abstract] [Full Text] [Related]
17. [Dysentery in the City of Białystok in the years 1961-1974].
Wyrzykowski J; Jezyna C; Wyrzykowska H
Przegl Epidemiol; 1976; 30(4):515-22. PubMed ID: 796895
[No Abstract] [Full Text] [Related]
18. [Treatment of chronic bacillary dysentery using a live anti-dysentery vaccine].
Istrati G; Meitert T; Ciufercu C; Sulea IT; Baron E; Jipa G; Popescu P; Eduard H; Antonescu O; Frunzetti L; Dobrescu A; Sulutiu E; Ionescu L; Tilica D; Ghisoiu V; Brinzac V; Ceauşescu I; Bădescu M
Arch Roum Pathol Exp Microbiol; 1973 Mar; 32(1):22-33. PubMed ID: 4585402
[No Abstract] [Full Text] [Related]
19. Safety and immunogenicity of Shigella sonnei-CRM9 and Shigella flexneri type 2a-rEPAsucc conjugate vaccines in one- to four-year-old children.
Passwell JH; Ashkenazi S; Harlev E; Miron D; Ramon R; Farzam N; Lerner-Geva L; Levi Y; Chu C; Shiloach J; Robbins JB; Schneerson R;
Pediatr Infect Dis J; 2003 Aug; 22(8):701-6. PubMed ID: 12913770
[TBL] [Abstract][Full Text] [Related]
20. HIV infection as a risk factor for shigellosis.
Baer JT; Vugia DJ; Reingold AL; Aragon T; Angulo FJ; Bradford WZ
Emerg Infect Dis; 1999; 5(6):820-3. PubMed ID: 10603219
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
